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 Introduction 
 Tissue engineering of heart valves represents a new 
experimental concept to fabricate viable and functional 
heart valve tissue from autologous cells. These tissue-en-
gineered heart valve constructs theoretically have the po-
tential to grow and to remodel which would be an impor-
tant advantage especially for pediatric patients requiring 
heart valve replacement early in life. While tissue-engi-
neered heart valves have successfully functioned in the 
pulmonary position in sheep, numerous issues need to be 
addressed before clinical application. For example, clini-
cally feasible cell sources, the role of mechanical factors 
(e.g. bioreactor conditioning) and modified growth me-
dia for final human implantation have to be investigated. 
Furthermore, the design of a tissue-engineered heart 
valve is an important factor to fulfill the functional
requirements of an implantable heart valve prosthesis
 [1–4] .
 To fabricate an implantable and functional heart valve, 
our laboratory focused on applying the principles of rap-
id prototyping in order to improve the design and the 
fabrication technique for tissue-engineered heart valve 
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 Abstract 
 We developed a new fabrication technique for 3-dimension-
al scaffolds for tissue engineering of human heart valve tis-
sue. A human aortic homograft was scanned with an X-ray 
computer tomograph. The data derived from the X-ray com-
puted tomogram were processed by a computer-aided de-
sign program to reconstruct a human heart valve 3-dimen-
sionally. Based on this stereolithographic model, a silicone 
valve model resembling a human aortic valve was generat-
ed. By taking advantage of the thermoplastic properties of 
polyglycolic acid as scaffold material, we molded a 3-dimen-
sional scaffold for tissue engineering of human heart valves. 
The valve scaffold showed a deviation of only  8 3–4% in 
height, length and inner diameter compared with the homo-
graft. The newly developed technique allows fabricating 
custom-made, patient-specific polymeric cardiovascular 
scaffolds for tissue engineering without requiring any suture 
materials.  Copyright © 2008 S. Karger AG, Basel 
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scaffolds resembling the anatomy of a native human heart 
valve  [5] . Currently we describe a fabrication technique 
to generate a 3-dimensional heart valve scaffold, which 
was designed in the shape of the natural aortic valve, to 
provide temporary mechanical support for the construc-
tion of a viable and surgically feasible human heart 
valve.
 Material and Methods 
 Prototyping Process 
 An aortic homograft was used as a prototype to fabricate an 
individual heart valve scaffold with the correct anatomy of the 
human aortic valve. The homograft had not been accepted for 
heart surgery because of a positive microbiological test and was 
prepared for computed tomography (CT) scanning under the 
guideline of the laboratory for homografts at the German Heart 
Institute Berlin. We had previously introduced the idea of 3-di-
mensional reconstruction of heart valves. However, the prepared 
valve was scanned by CT at 2 mm slice distance and 0.1  ! 0.1 mm 
pixel size within all slices. The image data derived from CT were 
processed with our in-house software (Amira-Anaplast) which 
performs the image segmentation (border extraction with an ap-
propriate density threshold). For specifying the region of valve 
location, the segmented images were further processed by a re-
gion-growing technique ( fig. 1 a, b). The 2-dimensional segment-
ed images were interpolated from adjacent sections above and be-
low to establish a visualized 3-dimensional aortic valve and root 
model. The 3-dimensional model was converted into a stereo-
lithographic (STL) model and fed to the FDM 3000 stereolithog-
raphy machine (Stratasys, Eden Prairie, Minn., USA) for con-
struction of a resinic STL heart valve model. In addition, a nega-
tive cast of the ventricular side of the aortic homograft was 
created to construct a subsequent heart valve scaffold.
 Scaffold Material 
 A polymeric material was used for the fabrication of a heart 
valve scaffold. Poly-4-hydroxybutyrate (P4HB; MW 700,000 by 
gel permeation chromatography, porosity 80%, pore size 80–240 
  m, thickness 300   m) is a biopolyester produced by a proprie-
tary fermentation process (Tepha, Cambridge, Mass., USA). P4HB 
is a semicrystalline, thermoplastic elastomer with a melting point 
of approximately 60 ° C and a glass transition temperature of
–51 ° C.
 Heart Valve Scaffold Fabrication 
 The STL silicone model was then used to fabricate a polymer-
ic heart valve. This consisted of 3 steps, as shown in  figure 2 . 
Firstly, a rectangular piece of the polymer is wrapped around the 
negative cast of the silicone STL model (ventricular side of the STL 
silicone model) and trimmed off the potential sinus of Valsalva to 
shape a stent-like scaffold  [4] . In the following step, another piece 
of polymer is wrapped around the stent-like polymeric scaffold 
and is fixed by a thermal processing technique. The upper edges 
of the polymer are trimmed according to the shape of the 3 leaf-
lets, gently pressed onto the negative cast and manually molded. 
The third step is to use a polymer patch to form the sinus of Val-
salva and the vascular wall of a valved conduit. The whole heart 
valve scaffold is then placed at 4–8 ° C for 24–48 h for cooling to 
develop the stable and exact shape of the aortic heart valve and 
root. Thus, in the whole process we accurately imitate the struc-
ture of the native aortic heart valve and use the thermoplastic 
technique to fabricate the trileaflet heart valve scaffold using a 
biodegradable porous polymer.
 Bioreactor Testing 
 The P4HB heart valve scaffold for tissue engineering was test-
ed in a bioreactor pulsed by a simple respirator (dual-phase con-
trol ventilator; Harvard Apparatus, Holliston, Mass., USA), with 
inspiration/expiration set to 30/70 and frequency to 50 strokes/
min. The testing device was completely transparent to facilitate 
observation of the function of the heart valve scaffold. The setup 
was connected to 2 sensor elements of a digital pressure monitor-
ing device (Hellige Cardioserv, Freiburg, Germany), as described 
previously  [5] .
 Results 
 STL Model Construction 
 Figure 1 shows the segmented but unprocessed CT 
scanning image of a heart valve by the region-growing 
technique. In comparison with the anatomy of a native 
heart valve, there is an unexpected area being segmented 
which does not represent the valve area ( fig. 1 a). With the 
help of the region-growing technique, the valve area is 
plotted out ( fig. 1 b). From the segmented images we re-
constructed the 3-dimensional STL model ( fig. 3 ). Based 
on the STL model, a silicone model with the exact valvular 
 Fig. 1.  a The segmented but unprocessed image of a heart valve 
derived from the CT scanning image. In comparison with the 
natural anatomical structure of the heart valve, there is an unex-
pected area being segmented (within the white circle) which does 
not represent the valve area.  b With the help of the region-grow-
ing technique, the valve area was plotted out. Black triangles rep-
resent the area of the sinus of Valsalva (green areas in the online 
version); white triangles show the area of leaflets and commis-
sures (black area). 
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design of the human aortic homograft was generated, and 
a negative cast from the ventricular side of the aortic ho-
mograft was created for the final scaffold fabrication. The 
STL silicone model was then used as a physiological pro-
totype for the tissue engineering of heart valve scaffolds.
 Fabrication of a Heart Valve Scaffold 
 Based on the STL silicone model, a 3-dimensional bio-
degradable heart valve scaffold was constructed ( fig. 4 ) 
by molding porous P4HB into the shape of a heart valve 
using the thermoplastic technique. This heart valve scaf-
fold was fabricated without any suture materials or addi-
tional stent and resembled the natural complex anatomi-
cal structure of the human aortic heart valve. Measuring 
of the ventricular outer diameter of the newly created 
heart valve showed a length of 22.5 mm compared with 
23.2 mm for the aortic homograft template. Height, 
length and inner diameter of the scaffold showed a de-
viation of  8 3–4%.
 The Function of the Heart Valve Scaffold 
 The constructed heart valve scaffold opened and 
closed synchronously in a pulsatile flow bioreactor under 
normal and supranormal flow and pressure conditions, 
65° C
1 2 3
 Fig. 2. Scaffold fabrication steps. (1) A 
rectangular film of composite polymer is 
wrapped around the negative silicone STL 
model, and the sinus of the scaffold is
cut out. (2) Polymeric scaffold P4HB is 
wrapped around the stent-like scaffold
to ultimately form the leaflets. The up-
per part of the silicone STL model will be
gently pressed onto the polymeric scaffold 
(leaflets) in order to form the leaflets.
(3) The polymeric conduit is wrapped 
around the whole valvular construct, and 
the characteristic sinus of Valsalva is 
formed by a thermal processing tech-
nique. 
4
1
3
5
2
C
o
lo
r v
er
si
o
n 
av
ai
la
b
le
 o
n
lin
e
Fig. 3. Three-dimensional reconstructed STL model built from 
the stereolithography machine (from the inside of an aortic root 
homograft). 1 = Negative cast of a coronary artery; 2 = aortic side 
of a leaflet; 3 = commissural part of the leaflets; 4 = ascending 
aorta; 5 = sinus of Valsalva.
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 Fig. 4.  a P4HB heart valve scaffold based on an STL model seen 
from the ventricular side.  b Same model seen from the aortic side. 
sV = Sinus of Valsalva. 
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with a maximum pressure gradient of 10 mm Hg under 
systemic systolic pressure conditions. Only mild stenosis 
and regurgitation were observed in the heart valve scaf-
fold ( table 1 ).
 Discussion 
 Valve replacement is the predominant treatment for 
end-stage valvular heart disease. Worldwide, up to 
300,000 heart valves are replaced each year, the currently 
used prosthetic heart valves being either mechanical or 
biological  [6] . Although mechanical valves exhibit excel-
lent durability, they are thrombogenic and require life-
long anticoagulation therapy. Bioprosthetic heart valves 
as well as homografts have appropriate hemodynamic 
properties; but their limited durability, premature calci-
fication, lack of growth potential and the intricate avail-
ability of donor organs restrict their application, espe-
cially in pediatric patients  [7–9] .
 Tissue engineering of heart valves could overcome 
these disadvantages. The success of any therapy involv-
ing the transplantation of cells relies on the development 
of suitable substrates for both in vitro and in vivo tissue 
culture  [10] . In our laboratory, we focused on using bio-
degradable polymers to shape regenerating heart valve 
tissue, provide temporary mechanical support and en-
hance tissue regeneration. Although tissue-engineered 
trileaflet heart valves based on synthetic biodegradable 
scaffolds have successfully functioned in the pulmonary 
circulation of sheep, the physiological valve scaffold ge-
ometry and fabrication remain a significant problem. In 
tissue engineering of functional implants such as heart 
valves, the initial shape of the biodegradable scaffold will 
guide the tissue development and is important for the fi-
nal hemodynamic function of the newly created heart 
valve construct. Stock et al. [6] reported the use of a cy-
lindrical valved conduit without any sinus of Valsalva 
and leaflets sutured to the conduit. Twenty-four weeks 
after implantation the authors described a thrombus for-
mation in the area of the leaflet suture which limits the 
hemodynamic function of the newly created heart valve 
construct  [6] . Based on this observation, we aim for a pre-
cise design combined with the avoidance of any sutures 
at the flow-exposed side to attain long-term function of 
the heart valve.
 Furthermore it is the authors’ opinion – in agreement 
with several specialists in the field – that an optimal valve 
design lowers the risk of design-related heart valve fail-
ure, the risk of suture-related thrombosis and inadequate 
tissue formation  [9] . The development of a rapid proto-
typing technique has made it possible to  reconstruct 
complex human valve structures. This rapid prototyping 
is defined as a group of techniques used to quickly fabri-
cate the physical models of tissue scaffolds and custom-
made tissue implant prostheses based on the advanced 
development of computer-aided design/computer-aided 
manufacturing to generate a 3-dimensional anatomical 
model  [10, 11] . Stereolithography, as one of the rapid pro-
totyping techniques, has already been used in cranio-
maxillofacial surgery and the construction of an aortic 
aneurysm model  [12, 13] . The accuracy and the ability to 
intimately control the overall macroscopic shape of the 
implants makes the rapid prototyping techniques an ide-
al process for fabricating implant and tissue engineering 
scaffolds.
 The rapid prototyping technique of stereolithography 
was applied to physiologically design a heart valve scaf-
fold which resembles the complex natural anatomical 
structure of a human aortic homograft using P4HB as 
scaffold material. In our current experiment, a new tech-
nique was developed to fabricate a heart valve scaffold for 
tissue engineering. Moreover, the polymer was molded 
into the shape of a custom-made heart valve using the 
thermoplastic technique without requiring any suturing 
in the valve leaflet formation.
 In this technical report we describe the detailed tech-
nical steps to fabricate a trileaflet heart valve scaffold in-
cluding the sinus of Valsalva to ultimately develop a cus-
tom-made heart valve prosthesis. Although early results 
appear promising, the tissue engineering of heart valves 
is a developing area, and numerous issues need to be ad-
dressed. We do not believe that only the valve design 
Table 1. Direct pressure measurements (mm Hg, means 8 SD) of 
the heart valve scaffold
Stroke
volume
Direct pressure measurements
distally to the heart
valve scaffold
proximally to the heart
valve scaffold
10 ml 5.480.89 8.6080.54
25 ml 7.280.45 8.6080.54
50 ml 27.480.55 29.8080.83
100 ml 49.481.52 52.2080.84
200 ml 10181.64 102.8080.84
300 ml 17280.55 171.6081.14
400 ml 21384.93 211.4081.14
500 ml 26484.39 264.2084.66
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leads to appropriate tissue formation, but physiological 
heart valve design is one significant factor in order to fab-
ricate an autologous heart valve substitute. One of the 
important areas is the use of scaffold materials with a 
controllable degradation rate, appropriate mechanical 
properties, high plasticity and favorable biocompatibility 
for the cells to attach, proliferate, form a matrix and fi-
nally develop new and functional tissue for an advanced 
heart valve replacement. Our research aims to apply im-
proved tissue engineering techniques to provide a pa-
tient-specific heart valve replacement for implantation.
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